Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00085696
Status:
COMPLETED
Last Update Posted:
2008-02-11
First Post:
2004-06-11
Brief Title:
VELCADE Bortezomib With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma
Sponsor:
Organization:
Millennium Pharmaceuticals Inc